Patrick Rossignol, Joao Pedro Ferreira. Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients.
JACC: Heart Failure, Elsevier/American College of Cardiology, 2019, 7 (1), pp.33-35.
⟨10.1016/j.jchf.2018.11.016⟩.
⟨hal-02510373⟩